In a major overhaul of India's drug regulations, the Union Ministry of Health and Family Welfare has made it mandatory for consumers to present a doctor's prescription before purchasing any medicinal syrup, including commonly used cough syrups.
The new rule, notified under the Drugs (Fifth Amendment) Rules, 2026, came into effect immediately after its publication in the Official Gazette on June 9, 2026. The amendment effectively ends the over-the-counter (OTC) sale of all medicinal syrups across the country.
Under the revised regulations, pharmacies and chemists can no longer sell medicinal syrups without a valid prescription issued by a registered medical practitioner.
Until now, certain syrup-based medicines, particularly cough syrups could be purchased without a prescription under exemptions provided by the Drugs Rules, 1945.
The latest amendment removes this exemption, bringing all syrup formulations under stricter regulatory oversight.
For consumers, this means that medicines commonly bought for ailments such as cough, cold, fever, or other conditions in syrup form will now require a doctor's consultation before purchase.
The regulatory change stems from an amendment to Schedule K of the Drugs Rules, 1945.
Schedule K lists medicines classified as "household remedies" that are exempt from certain licensing and prescription requirements.
Previously, Entry 7 under Serial Number 13 included:
"Syrups, lozenges, pills and tablets for cough."
The government has now removed the word "syrups" from this provision.
As a result, while cough lozenges, pills, and tablets continue to enjoy exemptions under Schedule K, cough syrups and other medicinal syrups no longer qualify for over-the-counter sale.
The exemption had also allowed such products to be sold in villages with populations below 1,000 where licensed pharmacies were unavailable. That provision will no longer apply to syrups.
In recent months, contaminated cough syrups have been linked to the deaths of children in India, triggering nationwide alarm.
Reports of child fatalities in Madhya Pradesh and Rajasthan intensified scrutiny of the manufacturing and distribution of syrup-based medicines.
Health authorities also reviewed broader concerns regarding the quality control of oral liquid formulations, many of which use solvents that can be vulnerable to contamination if manufacturing standards are compromised.
The government said the tighter regulations are intended to improve accountability, ensure safer consumption practices, and prevent unsafe medicines from reaching consumers without medical supervision.
The amendment did not emerge overnight.
The Ministry had first released draft rules in December 2025, inviting objections and suggestions from stakeholders and the public.
After reviewing the feedback received, the Centre finalised the proposal and issued the notification in June 2026.
The amendment was introduced under powers granted by the Drugs and Cosmetics Act, 1940, and formally notified as the Drugs (Fifth Amendment) Rules, 2026.
(Rh/ARC)
